BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 29567821)

  • 21. Predictors of Medicare costs in elderly beneficiaries with breast, colorectal, lung, or prostate cancer.
    Penberthy L; Retchin SM; McDonald MK; McClish DK; Desch CE; Riley GF; Smith TJ; Hillner BE; Newschaffer CJ
    Health Care Manag Sci; 1999 Jul; 2(3):149-60. PubMed ID: 10934539
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of approaches for estimating prevalence costs of care for cancer patients: what is the impact of data source?
    Yabroff KR; Warren JL; Banthin J; Schrag D; Mariotto A; Lawrence W; Meekins A; Topor M; Brown ML
    Med Care; 2009 Jul; 47(7 Suppl 1):S64-9. PubMed ID: 19536016
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Variation in Medicare Expenditures for Treating Perioperative Complications: The Cost of Rescue.
    Pradarelli JC; Healy MA; Osborne NH; Ghaferi AA; Dimick JB; Nathan H
    JAMA Surg; 2016 Dec; 151(12):e163340. PubMed ID: 27706473
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Standardizing Medicare payment information to support examining geographic variation in costs.
    O'Donnell BE; Schneider KM; Brooks JM; Lessman G; Wilwert J; Cook E; Martens G; Wright K; Chrischilles EA
    Medicare Medicaid Res Rev; 2013; 3(3):. PubMed ID: 24753972
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Total Medicare Costs Associated With Diagnosis and Treatment of Prostate Cancer in Elderly Men.
    Trogdon JG; Falchook AD; Basak R; Carpenter WR; Chen RC
    JAMA Oncol; 2019 Jan; 5(1):60-66. PubMed ID: 30242397
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Area-level variations in cancer care and outcomes.
    Keating NL; Landrum MB; Lamont EB; Bozeman SR; McNeil BJ
    Med Care; 2012 May; 50(5):366-73. PubMed ID: 22437623
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Rural-Urban Differences in Costs of End-of-Life Care for the Last 6 Months of Life Among Patients with Breast, Lung, or Colorectal Cancer.
    Crouch E; Eberth JM; Probst JC; Bennett K; Adams SA
    J Rural Health; 2019 Mar; 35(2):199-207. PubMed ID: 29656565
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The impact of hospital-acquired conditions on Medicare program payments.
    Kandilov AM; Coomer NM; Dalton K
    Medicare Medicaid Res Rev; 2014; 4(4):. PubMed ID: 25386385
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Estimating health care costs related to cancer treatment from SEER-Medicare data.
    Brown ML; Riley GF; Schussler N; Etzioni R
    Med Care; 2002 Aug; 40(8 Suppl):IV-104-17. PubMed ID: 12187175
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Esophageal cancer treatment costs by phase of care and treatment modality, 2000-2013.
    Tramontano AC; Chen Y; Watson TR; Eckel A; Hur C; Kong CY
    Cancer Med; 2019 Sep; 8(11):5158-5172. PubMed ID: 31347306
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Medical Care Costs Associated With Cancer in Integrated Delivery Systems.
    Banegas MP; Yabroff KR; O'Keeffe-Rosetti MC; Ritzwoller DP; Fishman PA; Salloum RG; Lafata JE; Hornbrook MC
    J Natl Compr Canc Netw; 2018 Apr; 16(4):402-410. PubMed ID: 29632060
    [No Abstract]   [Full Text] [Related]  

  • 32. Estimating Costs of Care Attributable to Cancer: Does the Choice of Comparison Group Matter?
    Chen AB; Li L; Cronin AM; Brooks GA; Kavanagh BD; Schrag D
    Health Serv Res; 2018 Aug; 53 Suppl 1(Suppl Suppl 1):3227-3244. PubMed ID: 28858372
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cancer-Attributable Medical Costs for Colorectal Cancer Patients by Phases of Care: What Is the Effect of a Prior Cancer History?
    Mariotto AB; Warren JL; Zeruto C; Coughlan D; Barrett MJ; Zhao L; Yabroff KR
    J Natl Cancer Inst Monogr; 2020 May; 2020(55):22-30. PubMed ID: 32412066
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The Cost of Initial Care for Medicare Patients With Advanced Ovarian Cancer.
    Urban RR; He H; Alfonso-Cristancho R; Hardesty MM; Goff BA
    J Natl Compr Canc Netw; 2016 Apr; 14(4):429-37. PubMed ID: 27059191
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Costs of Cancer Care for Elderly Patients with Neuroendocrine Tumors.
    Shen C; Dasari A; Gu D; Chu Y; Zhou S; Xu Y; Halperin D; Fu S; Yao JC; Shih YT
    Pharmacoeconomics; 2018 Aug; 36(8):1005-1013. PubMed ID: 29682693
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pancreatic cancer treatment costs, including patient liability, by phase of care and treatment modality, 2000-2013.
    Tramontano AC; Chen Y; Watson TR; Eckel A; Sheehan DF; Peters MLB; Pandharipande PV; Hur C; Kong CY
    Medicine (Baltimore); 2019 Dec; 98(49):e18082. PubMed ID: 31804317
    [TBL] [Abstract][Full Text] [Related]  

  • 37. What Drives Variation in Episode-of-care Payments for Primary TKA? An Analysis of Medicare Administrative Data.
    Cram P; Ravi B; Vaughan-Sarrazin MS; Lu X; Li Y; Hawker G
    Clin Orthop Relat Res; 2015 Nov; 473(11):3337-47. PubMed ID: 26239239
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Variation in Hospital Episode Costs With Bariatric Surgery.
    Grenda TR; Pradarelli JC; Thumma JR; Dimick JB
    JAMA Surg; 2015 Dec; 150(12):1109-15. PubMed ID: 26376433
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Rising Economic Burden of Renal Cell Carcinoma among Elderly Patients in the USA: Part II-An Updated Analysis of SEER-Medicare Data.
    Shih YT; Xu Y; Chien CR; Kim B; Shen Y; Li L; Geynisman DM
    Pharmacoeconomics; 2019 Dec; 37(12):1495-1507. PubMed ID: 31286464
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Associations Between End-of-Life Cancer Care Patterns and Medicare Expenditures.
    Wang SY; Hall J; Pollack CE; Adelson K; Davidoff AJ; Long JB; Gross CP
    J Natl Compr Canc Netw; 2016 Aug; 14(8):1001-8. PubMed ID: 27496116
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.